Estrogen prophylaxis. The U.S. Preventive Services Task Force.
Level V
Where this comes from
- Record sourced from PubMed, PMID 2239637.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although routine postmenopausal estrogen replacement is not recommended, estrogen therapy should be considered for asymptomatic women who are at increased risk for osteoporosis, who lack known contraindications and who have received adequate counseling about potential benefits and risks.